TABLE 2.

Qualitative assessment of efficacy at 3 months

Assessment	3 months follow‐up N = 22
≥1‐point improvement in IPR‐FWS, n (%)	21 (95.5%)
Change from baseline in IPR‐FWS, LS mean (95% CI)	−1.61 (−1.99, −1.23)
Change from baseline in Investigator‐FWS, mean ± SD	−2.6 ± 1.1
Modified Global Aesthetic Improvement Scale, n (%)	Investigator | Subjects
Very much improved	6 (27.3%) | 3 (13.6%)
Much improved	14 (63.6%) | 7 (31.8%)
Improved	2 (9.1%) | 10 (45.5%)
No change	0 | 2 (9.1%)
Worse	0 | 0
Much worse	0 | 0
Very much worse	0 | 0

Subgroup qualitative assessment of efficacy at 3 months including percent with >1 improvement in IPR‐FWS, change from baseline in IPR‐FWS and in Investigator‐FWS, Modified Global Aesthetic Improvement Scale results per Investigator and per Subjects.

Abbreviation: CI, confidence interval; FWS, Fitzpatrick wrinkle and elastosis scale; IPR, independent photographic reviewer; LS, least square; SD, standard deviation